987 related articles for article (PubMed ID: 29775645)
1. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.
Wang TF; Liou YS; Yang SH; Lin GL; Chiang YW; Lien TS; Li CC; Wang JH; Chang HH; Sun DS
Stem Cell Res Ther; 2023 Oct; 14(1):300. PubMed ID: 37864264
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
[TBL] [Abstract][Full Text] [Related]
4. Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.
Tay J; Levesque JP; Winkler IG
Int J Hematol; 2017 Feb; 105(2):129-140. PubMed ID: 27943116
[TBL] [Abstract][Full Text] [Related]
5. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization.
Kang KW; Lee SJ; Kim JH; Lee BH; Kim SJ; Park Y; Kim BS
BMC Cancer; 2020 Jul; 20(1):619. PubMed ID: 32615949
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
Delgaudine M; Gothot A; Beguin Y
Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
[TBL] [Abstract][Full Text] [Related]
7. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue.
Deng J; Zou ZM; Zhou TL; Su YP; Ai GP; Wang JP; Xu H; Dong SW
Neurol Sci; 2011 Aug; 32(4):641-51. PubMed ID: 21678074
[TBL] [Abstract][Full Text] [Related]
9. G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer's Disease Mice via CXCR4/SDF-1 Chemotaxis.
Wu CC; Wang IF; Chiang PM; Wang LC; Shen CJ; Tsai KJ
Mol Neurobiol; 2017 Oct; 54(8):6198-6212. PubMed ID: 27709493
[TBL] [Abstract][Full Text] [Related]
10. Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome.
Emmons R; Niemiro GM; Owolabi O; De Lisio M
J Appl Physiol (1985); 2016 Mar; 120(6):624-32. PubMed ID: 26744505
[TBL] [Abstract][Full Text] [Related]
11. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization.
Takamatsu Y; Simmons PJ; Moore RJ; Morris HA; To LB; Lévesque JP
Blood; 1998 Nov; 92(9):3465-73. PubMed ID: 9787189
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability.
Matsumoto T; Takamatsu Y; Moriyama H; Terada K; Mori M; Ono K; Migita K; Hara S
Exp Hematol; 2021 May; 97():21-31. PubMed ID: 33617894
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
[TBL] [Abstract][Full Text] [Related]
15. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
Christopher MJ; Liu F; Hilton MJ; Long F; Link DC
Blood; 2009 Aug; 114(7):1331-9. PubMed ID: 19141863
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.
Wright DE; Cheshier SH; Wagers AJ; Randall TD; Christensen JL; Weissman IL
Blood; 2001 Apr; 97(8):2278-85. PubMed ID: 11290588
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1.
Salvucci O; Jiang K; Gasperini P; Maric D; Zhu J; Sakakibara S; Espigol-Frigole G; Wang S; Tosato G
Haematologica; 2012 Jun; 97(6):818-26. PubMed ID: 22271895
[TBL] [Abstract][Full Text] [Related]
18. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
[TBL] [Abstract][Full Text] [Related]
19. Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.
Szumilas P; Barcew K; Baśkiewicz-Masiuk M; Wiszniewska B; Ratajczak MZ; Machaliński B
Cell Prolif; 2005 Feb; 38(1):47-61. PubMed ID: 15679866
[TBL] [Abstract][Full Text] [Related]
20. Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation.
Köse S; Aerts-Kaya F; Köprü ÇZ; Nemutlu E; Kuşkonmaz B; Karaosmanoğlu B; Taşkıran EZ; Altun B; Uçkan Çetinkaya D; Korkusuz P
Exp Hematol; 2018 Jan; 57():30-41.e1. PubMed ID: 29030083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
